Penn's Abramson Cancer Center part of major phase III study for myeloma

PHILADELPHIA Researchers from the Abramson Cancer Center of the University of Pennsylvania announced today that findings from two large, international clinical trials show unprecedented survival for patients with multiple myeloma, a cancer that occurs in the blood-making cells of bone marrow. The...

Promising hematologists begin year-long program to pursue careers in clinical research

...pital of Eastern Ontario, Ottawa, Ontario, Canada Matthew J. Olnes, MD, PhD, National Heart, Lung, and Blood Institute, Bethesda, MD Ran Reshef, MD, abramson Cancer Center, University of Pennsylvania, Philadelphia, PA Mark A. Schroeder, MD, Washington University School of Medicine in St. Louis, St. Louis, ...

Researchers Spot Genes Linked to Testicular Cancer

...rine L. Nathanson, an assistant professor of medicine at the University of Pennsylvania School of Medicine and a specialist in medical genetics at the abramson Cancer Center, said in a news release. Nathanson and colleagues found that men with two copies of the common version of the c-KIT ligand (KITLG) ge...

Compliance and cost: Bitter pills to swallow in the age of oral chemotherapy

...easons, that may not happen," says Angela DeMichele, MD, MSCE, an associate professor of Medicine and Epidemiology at the University of Pennsylvania's abramson Cancer Center, who will present a session called "Compliance and Cost: Bitter Pills to Swallow in the Era of Oral Cancer Treatment" on Sunday, May 31 ...

Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research

...cal School; and "Cutting off the Fuel Supply: A New Approach to the Treatment of Pancreatic Cancer" / Leaders: Craig B. Thompson, M.D., Director, abramson Cancer Center at the University of Pennsylvania, and Daniel D. Von Hoff, M.D., Senior Investigator and Physician in Chief at the Translational Researc...

$18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research

...-Chief, and Dr. Craig B. Thompson, Director of the abramson Cancer Center at Penn, are co-leaders of SU2C panc...ig Thompson In addition to his position at the abramson Cancer Center, Dr. Thompson is the Associate Vice ...sity of Pennsylvania Heath System, director of the abramson Family Cancer Research Institute and the John H. G...

Agios Pharmaceuticals' founders author Science review on cancer metabolism

..., Ph.D., Director of the Cancer Center at Beth Israel Deaconess Medical Center and Professor of Systems Biology and Craig B. Thompson, M.D., Director, abramson Cancer Center, University of Pennsylvania, and one of its scientific advisors, Matthew Vander Heiden, M.D., Ph.D., Instructor of Medicine, Dana Farb...

Penn's online survivorship care plans empower cancer survivors, caregivers

... Ninety-seven percent of people who used OncoLife, the first online cancer survivorship care plan tool developed by physicians and nurses from Penn's abramson Cancer Center rated their experience with the tool as "good" to "excellent," and 84 percent said they planned to share their plan with their health c...

Keynote Speakers Announced for 2009 Pharmacy Benefits Academy

... Harvard author Dr. John abramson and health care ethics expert Dr. John Golenski to address human resources,... better understand the ethical implications of pharmacy benefit design. Dr. abramson will share his perspectives as a general physician on how to take back heal...

Penn study examines power of exercise to prevent breast cancer

...ofessor in the Center for Clinical Epidemiology and Biostatistics who is leading the new study, in partnership with Susan Domchek, MD, director of the abramson Cancer Center's Cancer Risk Evaluation Program. "Exercise also has a number of health and stress reduction benefits that make it even more attractive ...

Abramson in Medical Technology

Gene Findings Unlocking Reasons for Neuroblastoma Risk

...tional Institutes of Health, the Alex's Lemonade Stand Foundation, the Evan Dunbar Foundation, the Rally Foundation, the Andrew's Army Foundation, the abramson Family Cancer Research Institute and the Giulio D'Angio Endowed Chair. Maris is also on the faculty of the University of Pennsylvania School o...

Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer

...urs harbour a BRAF mutation, as well as improved quality of life for symptomatic patients," stated Keith T. Flaherty, M.D., assistant professor at the abramson Cancer Center of the University of Pennsylvania and principal investigator for the PLX4032 phase I clinical trial. "Seven years after BRAF mutations...

Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting

...herapy (BiovaxID) in follicular lymphoma in first complete remission: Phase III clinical trial results Lead investigator: S. J. Schuster, abramson Cancer Center, University of Pennsylvania , Philadelphia, PA Abstract 2, Plenary Presentation, Sunday, May 31, 1:00 PM to 4:00 PM, Level ...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

...l ; and "Cutting off the Fuel Supply: A New Approach to the Treatment of Pancreatic Cancer" / Leaders: Craig B. Thompson, M.D., Director, abramson Cancer Center at the University of Pennsylvania , and Daniel D. Von Hoff, M.D., Senior Investigator and Physician in Chief at the Translational Resea...

Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis

...uture disease modifying drugs for OA to achieve optimal benefit." The new genetic findings are the result of research collaborations with Dr. Steven abramson and Dr. Mukundan Attur of the New York University Hospital for Joint Diseases and Dr. Virginia Byers Kraus of the Duke University Medical Center. The ...

Gene That Causes Childhood Cancer Neuroblastoma Is Found

...r-Murray Fund and the Carly Hillman Fund. The Center for Applied Genomics at The Children's Hospital of Philadelphia also provided support, as did the abramson Family Cancer Research Institute of the University of Pennsylvania School of Medicine. The study could not have been done, say the authors, without th...

Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells

...ategy for the treatment of HIV/AIDS. The work, which was carried out in the laboratory of Carl June, M.D., Director of Translational Research at the abramson Family Cancer Research Institute at the University of Pennsylvania School of Medicine, in collaboration with Sangamo scientists, was published as an A...

Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)

... second-line treatment of advanced colorectal cancer in patients with the K-Ras gene mutation," said Daniel Haller, M.D., Professor of Medicine at the abramson Cancer Center at the University of Pennsylvania. "This novel oncolytic, NKTR-102, could offer an alternative and promising approach for tumors in this...

Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer

...nd TUSTIN, Calif., May 31 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported that clinical researchers from the abramson Cancer Center of the University of Pennsylvania will present data showing that its brain cancer agent Cotara(R) specifically localizes to brain tumors...

Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania

...-L for recurrent ovarian cancer, has begun at The University of Pennsylvania Center for Research on Early Detection and Cure of Ovarian Cancer and the abramson Cancer Center. The first patients have been enrolled and have undergone initial treatment steps in preparation for receiving DCVax(R)-L. The trial inv...

Abramson in Medical Products

Silicone Abramson triple-lumen sheath sump drain with filter

Description: Used in the peritoneal cavity to remove large volumes of thick exudate....
Company:Bard Medical

Abramson in Biological News

Promising device snags young inventors coveted spot at IShow

...nt Nithin Rajan and Steve Xu, who both work at the abramson Center for the Future of Health in the Texas Medic...ple to use," said Dr. Cliff Dacso, director of the abramson Center, the John S. Dunn Sr. Research Chair in Gen...t," Rajan said. The device was developed at the abramson Center for the Future of Health, a joint partnersh...

Penn researchers discover genetic risk factor for testicular cancer

... for most cases of testicular cancer," says Katherine L. Nathanson, MD, an assistant professor of Medicine and a specialist in medical genetics at the abramson Cancer Center. "These variants are the first striking genetic risk factors found for this disease to date." Nathanson and co-author Peter A. Kanetsk...

Researchers at UH explore patient preferences for personalized medicine

...olicymakers and physicians. The team will be led by Amalia M. Issa, who heads the Program in Personalized Medicine and Targeted Therapeutics at the abramson Family Center for the Future of Health, a joint initiative between UH and The Methodist Hospital Research Institute. Personalized medicine uses a geno...

UCLA researchers clarify function of glucose transport molecule

... drugs designed to treat patients with diabetes and cancer. Led by Jeff abramson and Ernest Wright of the UCLA Department of Physiology, the research team p...he ability to rationally design these drugs. In ongoing work, Wright and abramson are examining the manner in which inhibitors of the transporter proteins mo...

Loss of stem cells correlates with premature aging in animal study

... Researchers at the abramson Family Cancer Research Institute of the University of Pennsylvania have found that deleting a gene important in embryo development leads to premature ...

An AIDS-related virus tricks cells to become tumors, new Penn study finds

...regulation of these major cell proteins," says lead author Erle Robertson, PhD, Professor of Microbiology and the Director of Tumor Virology at Penn's abramson Cancer Center. Marked for Disposal The trick is played out in a cell process called ubiquitylation. This refers to a pathway in all cells whereby...

Older men treated for early prostate cancer live longer than those who are not

... were at a low or intermediate risk of spreading," said senior author Katrina Armstrong, MD, MSCE, who worked on the study with colleagues from Penn's abramson Cancer Center, Center for Clinical Epidemiology and Biostatistics, Leonard Davis Institute of Health and Economics, and Division of Internal Medicine,...

'Tribbles' protein implicated in common and aggressive form of leukemia

... blood. AML is the most common type of leukemia in adults, with an estimated 10,100 new cases reported each year. Pear, also a researcher in the abramson Family Cancer Research Institute at Penn; first author and postdoctoral fellow Karen Keeshan, PhD; and colleagues found Tribbles by chance when lookin...

Cell death following blood 'reflow' injury tracked to natural toxin

...gehammer, or a death switch. "We've found evidence of it in cells following all types of injury," says Ted Dawson, M.D., Ph.D., the Leonard and Madlyn abramson Professor of Neurodegenerative Diseases, professor of neurology and co-director of Hopkins' Neuroregeneration and Repair Program in the Institute of C...

Blood test predicts success of quitting smoking using the nicotine patch

...er to succeed in quitting," said lead researcher for the study, Caryn Lerman, PhD, Associate Director for Cancer Control and Population Science at the abramson Cancer Center of the University of Pennsylvania, and Director of the University of Pennsylvania Transdisciplinary Tobacco Use Research Center. When...

Abramson in Biological Technology

First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418

...Dwyer, Professor of Medicine at the University of Pennsylvania School of Medicine and Program Leader of the Experimental Therapeutics Program at the abramson Cancer Center of the University of Pennsylvania , and by Dr. Gabriela Chiorean, Assistant Professor of Medicine at the Indiana University School of ...

Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS

...IV and we are very excited to begin a clinical trial of this novel ZFN-based therapy," said Carl June, M.D., Director of Translational Research at the abramson Family Cancer Research Institute at the University of Pennsylvania School of Medicine. "The ability to protect immune cells from infection with HIV ...

Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic

...out these data and our collaboration with Sangamo to develop an HIV/AIDS therapeutic," said Carl June, M.D., Director of Translational Research at the abramson Family Cancer Research Institute at the University of Pennsylvania School of Medicine, and a co-author of the study. "The ability to prevent immune ce...